Careers  |  Sign In  |  Register

Latest in Cardiology

Risk of myocardial ischemia

Avandia’s New Warning

This update highlights changes to the prescribing information for Avandia including a new boxed warning about the potential increased risk of myocardial ischemia. References and Resources FDA adds a new warning about the risk of myocardial ischemia to the boxed warning for Avandia. Click Here to...

Increased risk of death with Trasylol

Suspension of Proteinase Inhibitor

The FDA announced that Trasylol increases risk of death, and therefore a marketing suspension has occurred. References and Resources FDA Requests Marketing Suspension of Trasylol Click Here to read the update. Sponsored by Thr Doctor's...
A meeting of the Circulatory System Devices Panel discussed the premarket approval for Endeavor, and voted unanimously in favor of “Approvable with Conditions.” References and Resources Circulatory System Devices Panel Click Here to read the panel discussion. ...